Biomerieux SA
OTC:BMXXY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomerieux SA
OTC:BMXXY
|
FR |
|
Unibail-Rodamco-Westfield SE
F:1BR1
|
FR |
|
Balfour Beatty PLC
LSE:BBY
|
UK |
|
Abo-Group Environment NV
XBRU:ABO
|
BE |
|
H
|
Hextar Technologies Solutions Bhd
KLSE:HEXTECH
|
MY |
|
R
|
RTW Biotech Opportunities Ltd
LSE:RTW
|
GG |
|
W
|
Web Travel Group Ltd
SWB:WBJ
|
AU |
|
L
|
Lungyen Life Service Corp
TPEX:5530
|
TW |
|
E
|
Emerson Electric Co
F:EMR
|
US |
|
RS Group PLC
LSE:RS1
|
UK |
|
D
|
Digital Workforce Services Oyj
OMXH:DWF
|
FI |
|
S
|
Sorrento Resources Ltd
OTC:SRSLF
|
CA |
|
Safilo Group SpA
MIL:SFL
|
IT |
|
Axis Bank Ltd
NSE:AXISBANK
|
IN |
|
J
|
Jazan Energy and Development Company SJSC
SAU:6090
|
SA |
|
Circle8 Group Inc
NASDAQ:CIRC
|
US |
|
U
|
Ultra Brands Ltd
CNSX:ULTA
|
CA |
|
Finseta PLC
F:90W
|
UK |
|
S
|
Sardar Chemical Industries Ltd
KAR:SARC
|
PK |
|
B
|
Bouygues SA
F:BYG
|
FR |
|
Wolters Kluwer NV
AEX:WKL
|
NL |
|
C
|
CapitaLand Ascendas REIT
OTC:ACDSF
|
SG |
|
Inventiva SA
PAR:IVA
|
FR |
|
N
|
NOVABASE SGPS SA
XMUN:NVQ
|
PT |
Intrinsic Value
Is BMXXY undervalued or overvalued?
See the intrinsic value estimate for 
Biomerieux SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
BMXXY looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with BMXXY’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Biomerieux Does
bioMérieux makes laboratory tests that help doctors and companies find microbes and understand whether a sample is safe. Its products include testing instruments, disposable reagents, software, and service contracts. In hospitals and public labs, these tests are used to identify infections and guide treatment decisions.
- Headquarters
- France FR
- Employees
- 14 894
- IPO date
- Jun 7, 2004
Biomerieux has no economic moat
Hospitals, laboratories and industrial customers can choose among competing diagnostic systems, and bioMérieux’s products do not become more valuable just because more customers use them. Its strong presence in some areas does not prevent rivals from competing for buyers or guarantee that customers will pay more for its name alone.
Read the full moat analysis
Earnings Waterfall
Biomerieux SA
The intrinsic value for Biomerieux SA (BMXXY) under the Base Case is hidden USD.
Compared with the current market price of 10.19 USD, the stock appears hidden.